France’s 2030 Health Initiative is driving growth in biotechnology, health innovation, biomanufacturing, and digital health.
News|Articles|August 2, 2004
- Pharmaceutical Technology-08-02-2004
- Volume 28
- Issue 8
Increased Outsourcing Driving Investments in CRO Industry
Author(s)Jim Miller
The contract services industry is fertile ground for the investment banking community this summer.
Advertisement
Articles in this issue
over 22 years ago
Stable Isotopic Characterization of Analgesic Drugsover 22 years ago
August 2004over 22 years ago
E-Health Information Campaign Shapes Pharmaceutical Regulationover 22 years ago
In the Spotlight-August 2004over 22 years ago
Interphex Delivers Packaging Solutionsover 22 years ago
Vapor-Phase Hydrogen Peroxide Resistance of Environmental Isolatesover 22 years ago
Decoding the US PharmacopeiaAdvertisement
Related to this article
argenx will acquire Unnatural Products for up to $1.15B, bringing oral macrocyclic peptides and new formulation challenges to its antibody portfolio.
CDMOs, OEMs, and Used Equipment Resellers are Joining Forces to Onshore Pharmaceutical Manufacturing
Onshoring pharmaceutical manufacturing can be made more practical by collaborating with CDMOs that have gray space, supported by strong relationships with used equipment dealers and OEMs.
Boehringer, AbbVie, ASKA, and Evommune license ADC, IBD, thyroid eye disease, and degrader assets, raising tech transfer demands for manufacturers.
CDMOs announced expansions, exhibitors showcased automated equipment, and supply chain strategy discussions were a focus at CPHI Milan 2026.
Mitigating nitrosamine risk requires assessing each product individually and chasing zero nitrite in pharmaceutical excipients is often impractical and costly.
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Why Drug Shortages Average 5+ Years: PharmTech Explained
2
CDMOs, OEMs, and Used Equipment Resellers are Joining Forces to Onshore Pharmaceutical Manufacturing
3
$1.15B AI-Guided Macrocycle Discovery Lands at argenx
4
Drapeau’s AI Deep Dive: Qualify the Reviewer Before the AI Goes Live
5